Literature DB >> 18023878

Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease.

Birgit Liss1, Jochen Roeper.   

Abstract

Dopaminergic midbrain neurons are involved in many important brain functions including motor control, as well as emotive and cognitive tasks. They also play critical roles in major disorders likes Parkinson disease, schizophrenia, drug abuse and attention-deficit hyperactivity disorder. This bewildering diversity of distinct dopaminergic functions appears to be in contrast to the routinely assumed functional homogeneity of dopaminergic midbrain neurons at the level of individual cells. If they indeed would conform to a single stereotypical phenotype, the functional diversity of dopaminergic neurons would be predominantly mediated by their involvement in anatomically distinct subcortical and cortical neuronal networks and their distinct postsynaptic targets. However, there is increasing evidence for functional diversity as well as plasticity within the population of dopaminergic midbrain neurons. In addition, dopaminergic midbrain neurons are also not homogeneously affected by disease processes, but instead show large differences in their relative vulnerability, especially their susceptibility to cell death in Parkinson disease. Here, we review recent progress in understanding diversity and flexibility of individual dopaminergic midbrain neurons at molecular and functional levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023878     DOI: 10.1016/j.brainresrev.2007.10.004

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  34 in total

1.  Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances.

Authors:  Zayd M Khaliq; Bruce P Bean
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  Firing properties and functional connectivity of substantia nigra pars compacta neurones recorded with a multi-electrode array in vitro.

Authors:  Nicola Berretta; Giorgio Bernardi; Nicola B Mercuri
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

3.  Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

Authors:  Bruno A Benítez; Helen M Belálcazar; Agustín Anastasía; Daniel T Mamah; Charles F Zorumski; Daniel H Mascó; Daniel G Herrera; Gabriel A de Erausquin
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

Review 4.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 5.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

Review 6.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

7.  Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.

Authors:  Konrad M Ricke; Thomas Paß; Sammy Kimoloi; Kai Fährmann; Christian Jüngst; Astrid Schauss; Olivier R Baris; Marijana Aradjanski; Aleksandra Trifunovic; Therese M Eriksson Faelker; Matteo Bergami; Rudolf J Wiesner
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

8.  Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuse.

Authors:  Silas A Buck; Mary M Torregrossa; Ryan W Logan; Zachary Freyberg
Journal:  FEBS J       Date:  2020-08-11       Impact factor: 5.542

Review 9.  Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.

Authors:  Nao Chuhma; Susana Mingote; Abigail Kalmbach; Leora Yetnikoff; Stephen Rayport
Journal:  Biol Psychiatry       Date:  2016-07-12       Impact factor: 13.382

10.  Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.

Authors:  Artem Kaplan; Krista J Spiller; Christopher Towne; Kevin C Kanning; Ginn T Choe; Adam Geber; Turgay Akay; Patrick Aebischer; Christopher E Henderson
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.